Baseline Thrombocytopenia

1

Review clinical trials related to Baseline Thrombocytopenia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

The use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Methodist Health SystemUpdated: Jun 10, 2026Locations: 1
Eligibility criteria

≥ 18 years [+3]

Death within 48 hours post-PCI [+1]